Response to Hasan et al's "Dupilumab therapy for atopic dermatitis is associated with increased risk of cutaneous T cell lymphoma: A retrospective cohort study".

Shih, Po-Cheng; Wei, James Cheng Chung

Response to Hasan et al's "Dupilumab therapy for atopic dermatitis is associated with increased risk of cutaneous T cell lymphoma: A retrospective cohort study".

Shih, Po-Cheng; Wei, James Cheng Chung.

Afiliación

Shih PC; Division of Allergy, Immunology, Rheumatology, Changhua Christian Hospital, Changhua, Taiwan. Electronic address: robertpcshih@gmail.com.
Wei JCC; Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan; Graduate Institute of Integrated Medicine, China Medical University, Taichung, Taiwan; Department of Nursing, Chung Shan Medical University, Taichung, Taiwan; Division of Allergy, Immunology and Rheumatology, Chung Shan Medical University Hospital, Taichung, Taiwan. Electronic address: jccwei@gmail.com.

J Am Acad Dermatol ; 91(5): e137-e138, 2024 Nov.

Article en En | MEDLINE | ID: mdl-39002563

Palabras clave

adverse effects; atopic dermatitis; biological therapy; lymphoma; real-world evidence

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: J Am Acad Dermatol Año: 2024 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google